HERON THERAPEUTICS, INC. /DE/ cotiza a 0.39 USD y tiene una capitalización bursátil de $74M. En los últimos 12 meses ha facturado $151M con un margen de flujo de caja libre del -18.0%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacolo…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.03 | $-0.04 | $-0.02 |
| Estimado | $-0.02 | $-0.02 | $-0.02 | $-0.03 |
| Sorpresa | — | -50.0% | -100.0% | +33.3% |
| Métrica | HRTX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 73.3% | 57.0% | +16.3% |
| Operating Margin | -1.6% | -38.6% | +37.0% |
| Net Margin | -13.0% | -33.6% | +20.5% |
| FCF Margin | -18.0% | -13.9% | -4.2% |
| ROE | -140.9% | -40.4% | -100.5% |
| ROA | -7.9% | -32.0% | +24.1% |
| Current Ratio | 2.48 | 2.84 | -0.36 |
| Debt / Equity | — | 0.28 | — |